The first vaccine from China has been finished its phase 1 human The Ad5-nCov is performing very well as a natural infection it is especially good at guiding the immune system to fight against the Coronavirus.
The entire world is expecting for a Coronavirus vaccine so the pandemic can end. The Coronavirus pandemic has infected over 6million people across the world with over 365,000 passed away and 2.75million people have been recovered.
The first vaccine from China has been finished its phase 1 human trials, the process and results are now online for everybody to examine.
According the Lancet paper a respected medical journal in the UK, published the results on Friday, saying it is “safe” and “induces rapid immune response.”
The research was conducted on 108 volunteers they received an injection and they were divided into 3 groups, therefore each group got a different dosage of the vaccine, there they could see which dosage was effective.
The vaccine has been called as “recombinant adenovirus type-5 vectored” (Ad5-nCov)
The Ad5-nCov is performing very well as a natural infection it is especially good at guiding the immune system to fight against the virus.
After 28 day of the injection, there were no serious reactions found, that will say that the vaccine is tolerable by humans.
In addition antibodies important to fight the virus, around 2 weeks after the injection Antibodies were surging and it reached its peak on day 28.
The vaccine “warrants Further Investigation,” the paper on The Lancet concluded, however the results were very good.